Pulmonary Endothelium-Bound Enzymes in the Normal and the Diseased Lung

  • S. E. Orfanos
  • A. Kotanidou
  • C. Roussos
Conference paper

Abstract

The most intimai layer covering all blood vessels is composed of a single, continuous sheet of simple squamous epithelial cells of mesenchymal origin, which are called endothelial cells. Endothelial cells possess numerous important metabolic properties. In the human lung, endothelial cells constitute over 40% of all cell types and occupy an area with a surface of approximately 130 m2 [1]. The strategic location of the lungs, and the tremendous surface area of the pulmonary capillary endothelium allow the latter to filter the entire circulating blood volume before it enters the systemic circulation. Healthy pulmonary endothelium, among other features, promotes anti-aggregation and hemofluidity; synthesizes and/or degrades several hormones and vasoactive peptides such as angiotensin II, nitric oxide (NO), endothelins, and prostaglandins (regulating both pulmonary and systemic vascular tones); processes lipids; and interacts with blood components such as neutrophils, monocytes, and platelets [2, 3]. Consequently, the pulmonary endothelium is a major metabolic organ necessary for the adequate homeostasis of both the pulmonary and systemic circulations.

Keywords

Angiotensin Converting Enzyme Acute Lung Injury Adult Respiratory Distress Syndrome Angiotensin Converting Enzyme Activity Pulmonary Endothelium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Simionescu M (1991) Lung endothelium: Structure-function correlates. In: Crystal RG, West JB (eds) The Lung: Scientific Foundations. Raven Press, New York, pp 301–312Google Scholar
  2. 2.
    Hassoun PM, Fanburg BL, Junod AF (1991) Metabolic functions. In: Crystal RG, West JB (eds) The Lung: Scientific Foundations. Raven Press, New York, pp 313–327Google Scholar
  3. 3.
    Orfanos SE, Catravas JD (1993) Metabolic Functions of the pulmonary endothelium. In: Yacoub M, Pepper J (eds) Annual Review of Cardiac Surgery, 6th edn. Current Science London, pp 52–59Google Scholar
  4. 4.
    Catravas JD, Orfanos SE (1997) Pathophysiologic functions of endothelial angiotensin-converting enzyme. In: Born GVR, Schwartz CJ (eds) Vascular Endothelium: Physiology, Pathology and Therapeutic Opportunities. Schattauer Stuttgart, pp 193–204Google Scholar
  5. 5.
    Ryan JW, Ryan US (1982) Processing of endogenous polypeptides by the lung. Annu Rev Physiol 44: 241–255PubMedCrossRefGoogle Scholar
  6. 6.
    Ryan JW, Smith US (1971) Metabolism of adenosine-5’-monophosphate during circulation through the lungs. Trans Assoc Am Physicians 84: 297–306PubMedGoogle Scholar
  7. 7.
    Ryan US, Ryan JW (1977) Correlations between the fine structure of the alveolar-capillary unit and its metabolic activities. In: Bakhle YS, Vane JR (eds) Metabolic Functions of the Lung. Marcel Dekker, New York, pp 197–232Google Scholar
  8. 8.
    Chen XL, Orfanos SE, Ryan JW, et al (1991) Species variation in pulmonary endothelial aminopeptidase P activity. J Pharmacol Exp Ther 259: 1301–1307PubMedGoogle Scholar
  9. 9.
    Battistini B, Dussault P (1998) Biosynthesis, distribution and metabolism of endothelins in the pulmonary system. Pulm Pharmacol Ther 11: 79–88PubMedCrossRefGoogle Scholar
  10. 10.
    Langleben D, Demarchie M, Laporta D, et al (1993) Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Respir Dis 148: 1646–1650PubMedCrossRefGoogle Scholar
  11. 11.
    Dupuis J, Goresky CA, Junear C (1990) Use of norepinephrine uptake to measure lung capillary recruitment with exercise. J Appl Physiol 68: 700–713PubMedGoogle Scholar
  12. 12.
    Dupuis J, Goresky CA, Rouleau JL, Simard A, Schwab AJ (1996) Kinetics of pulmonary uptake of serotonin during exercise in the dog. J Appl Physiol 80: 30–46PubMedCrossRefGoogle Scholar
  13. 13.
    Dupuis J, Stewart DJ, Cernacek P, Gosselin G (1996) Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 94: 1578–1584PubMedCrossRefGoogle Scholar
  14. 14.
    Gillis CN, Pitt BR, Wiedemann HP, et al (1986) Depressed prostaglandin E1 and 5-Hydroxytryptamine removal in patients with adult respiratory distress syndrome. Am Rev Respir Dis 134: 739–744PubMedGoogle Scholar
  15. 15.
    Morel DR, Dargent F, Bachmann M, et al (1985) Pulmonary extraction of serotonin and propranolol in patients with adult respiratory distress syndrome. Am Rev Respir Dis 132: 479–484PubMedGoogle Scholar
  16. 16.
    Pitt BR, Lister G, Gillis CN. (1987) Hemodynamic effects on lung metabolic function. In: Ryan US (ed) Pulmonary Endothelium in Health and Disease. Marcel Dekker, New York, pp 65–87Google Scholar
  17. 17.
    Ryan JW, Catravas JD (1991) Angiotensin converting-enzyme as an indicator of pulmonary microvascular funtion In: Hollinger MA (ed). Focus on Pulmonary Pharmacology Toxicology. CRC Press, Boca Raton, pp 183–210Google Scholar
  18. 18.
    Catravas JD, White RE. (1984) Kinetics of pulmonary angiotensin-converting enzyme and 5’-nucleotidase in vivo. J Appl Physiol 57: 1173–1181PubMedGoogle Scholar
  19. 19.
    Toivonen HJ, Catravas JD (1991) Effects of blood flow on lung ACE kinetics: Evidence for microvascular recruitment. J Appl Physiol 71: 2244–2254Google Scholar
  20. 20.
    Orfanos SE, Ehrhart IC, Barman S, Hofman WF, Catravas JD (1997) Endothelial ectoenzyme assays estimate perfused capillary surface area in the dog lung. Microvasc Res 54: 145–155PubMedCrossRefGoogle Scholar
  21. 21.
    Orfanos SE, Langleben D, Khoury J, et al (1999) Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans. Circulation 99: 1593–1599PubMedCrossRefGoogle Scholar
  22. 22.
    Ryan JW (1987) Assay of pulmonary endothelial surface enzymes in vivo. In: Ryan US (ed) Pulmonary Endothelium in Health and Disease. Marcel Dekker, New York USA, pp 161–188Google Scholar
  23. 23.
    Orfanos SE, Chen XL, Ryan JW, Chung AYK, Burch SE, Catravas JD (1994) Assay of pulmonary microvascular endothelial angiotensin-converting enzyme in vivo: comparison of three probes. Toxicol Appl Pharmacol 124: 99–111PubMedCrossRefGoogle Scholar
  24. 24.
    Segel IH (1975) Enzyme Kinetics. Wiley, New YorkGoogle Scholar
  25. 25.
    Orfanos SE, Kotanidou A, Roussos C (2002) Pulmonary endothelial angiotensin converting enzyme activity in lung injury. In: Vincent JL (ed) 2002 Yearbook of Intensive Care and Emergency Medicine. Springer, Heidelberg, pp 100–110Google Scholar
  26. 26.
    Catravas JD (1986) Michaelis-Menten kinetics of pulmonary endothelial angiotensin converting enzyme in the conscious rabbit. In: Greenbaum LM, Magnolius HS (eds) Kinins IV. Plenum, New York, pp 445–451CrossRefGoogle Scholar
  27. 27.
    Bernard GR, Artigas A, Brigham KL, et al (1994) The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 49: 818–824CrossRefGoogle Scholar
  28. 28.
    Ryan JW, Falido MJ, Sequeira MJ, et al (1994) Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo. J Pharmacol Exp Ther 270: 260–268PubMedGoogle Scholar
  29. 29.
    Chen I, Pitt BR, Moalli R, Gillis CN (1984) Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits. J Pharmacol Exp Ther 229: 649–653PubMedGoogle Scholar
  30. 30.
    Esther CR, Marino EM, Howard TE (1997) The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 99: 2375–2385PubMedCrossRefGoogle Scholar
  31. 31.
    Orfanos SE, Parkerson J, Fisher E, Catravas JD (1998) Estimation of dissociation constants for pulmonary endothelial angiotensin converting enzyme reactions with trandolaprilat and enalaprilat in vivo. Drug Dev Res 44: 80–86CrossRefGoogle Scholar
  32. 32.
    Catravas JD, Burch SE, Sprulock BO, Mills LR, et al (1988) Early effects of ionising radiation on pulmonary endothelial angiotensin converting enzyme and 5’-nucleotidase, in vivo. Toxicol Appl Pharamacol 94: 342–355CrossRefGoogle Scholar
  33. 33.
    Orfanos SE, Chen XL, Burch SE, Ryan JW, Chunk AYK, Catravas JD (1994) Radiation-induced early pulmonary endothelial ectoenzyme dysfunction in vivo: effect of indomethacin. Toxicol Appl Pharmacol 124: 112–122PubMedCrossRefGoogle Scholar
  34. 34.
    Chen XL, Orfanos SE, Catravas JD (1992) Effects of indomethacin on PMA-induced pulmonary endothelial enzyme dysfunction, in vivo. Am J Physiol 262: L153 - L162PubMedGoogle Scholar
  35. 35.
    Orfanos SE, Parkerson JB, Chen XL, et al (2000) Reduced lung endothelial angiotensin-converting enzyme activity in Watanabe hyperlipidemic rabbits in vivo. Am J Physiol 278: L1280 - L1288Google Scholar
  36. 36.
    Orfanos SE, Armaganidis A, Glynos C, et al (2000) Pulmonary capillary endothelium-bound angiotensin converting enzyme activity in acute lung injury. Circulation 102: 20112018Google Scholar
  37. 37.
    Orfanos SE, Psevdi E, Stratigis N, et al (2001) Pulmonary capillary endothelial dysfunction in early systemic sclerosis. Arthritis Rheum 44: 902–911PubMedCrossRefGoogle Scholar
  38. 38.
    Kaltsas P, Korovesi I, Mavrommati I, et al (2002) Pulmonary endothelial ACE dysfunction in mechanically ventilated patients. Intensive Care Med 28 (suppl 1 ): S89 (abst)Google Scholar
  39. 39.
    Orfanos SE, Glynos C, Mavrommati I, et al (2002) Pulmonary capillary endothelium-bound angiotensin converting enzyme activity reduction in brain-dead subjects: potential cytokine involvement. Am J Respir Crit Care Med 165: A102 (abst)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • S. E. Orfanos
  • A. Kotanidou
  • C. Roussos

There are no affiliations available

Personalised recommendations